Gharipour Mojgan, Kelishadi Roya, Sarrafzadegan Nizal, Baghaei Abdolmehdi, Yazdani Mehrdad, Anaraki Jafar, Eshrati Babak, Tavassoli Ali Akbar
Biochemistry Department, Isfahan Cardiovascular Research Centre, Isfahan University of Medical Sciences, Isfahan, Iran.
Ann Acad Med Singap. 2008 Nov;37(11):919-23.
There is limited evidence about the association between smoking and metabolic syndrome (MS). The aim of this study was to assess the association of smoking with MS components.
As part of the baseline survey of a community-based study, we studied 5,573 non-diabetic men. All participants were interviewed and underwent physical examinations and blood collection.
The study participants comprised 1,625 smokers and 3,948 non-smokers, with a mean age of 38.07 +/- 14.85 years. Serum low-density lipoprotein-cholesterol (LDL-C) and triglycerides (TG) were higher in smokers than in non-smokers (LDLC: 115.34 +/- 39.03 vs 112.65 +/- 40.94 mg/dL, respectively, P = 0.015 and TG: 175.13 +/- 102.05 vs 172.32 +/- 116.83 mg/dL, respectively, P = 0.005). Body mass index, waist circumference and waist-hip ratio were lower in smokers than in non-smokers. Mean systolic and diastolic blood pressures were significantly lower in smokers than in non-smokers (systolic: 112.06 +/- 15.888 vs 117.25 +/- 17.745 mmHg, respectively, P = 0.000; diastolic: 73.66 +/- 10.084 vs 76.23 +/- 10.458 mmHg, respectively, P = 0.000). The percentage of individuals with 2 MS components was higher in smokers than in non-smokers (39.64% vs 33.00%, respectively, P = 0.000). However, the percentage of non-smokers with 3 MS components was higher than in smokers (49.62 % vs 43.82%, respectively, P = 0.000).
Our findings support the hypothesis that lifestyle factors such as smoking can adversely affect MS components. However, we should acknowledge that these differences may have resulted from the large sample sizes studied and may not be clinically significant. The lower prevalence of some MS components in smokers than in nonsmokers might be because of their lower anthropometric measures.
关于吸烟与代谢综合征(MS)之间关联的证据有限。本研究的目的是评估吸烟与MS各组分之间的关联。
作为一项基于社区研究的基线调查的一部分,我们研究了5573名非糖尿病男性。所有参与者均接受了访谈、体格检查并进行了血液采集。
研究参与者包括1625名吸烟者和3948名非吸烟者,平均年龄为38.07±14.85岁。吸烟者的血清低密度脂蛋白胆固醇(LDL-C)和甘油三酯(TG)高于非吸烟者(LDL-C分别为115.34±39.03与112.65±40.94mg/dL,P = 0.015;TG分别为175.13±102.05与172.32±116.83mg/dL,P = 0.005)。吸烟者的体重指数、腰围和腰臀比低于非吸烟者。吸烟者的平均收缩压和舒张压显著低于非吸烟者(收缩压分别为112.06±15.888与117.25±17.745mmHg,P = 0.000;舒张压分别为73.66±10.084与76.23±10.458mmHg,P = 0.000)。有2种MS组分的个体百分比在吸烟者中高于非吸烟者(分别为39.64%与33.00%,P = 0.000)。然而,有3种MS组分的非吸烟者百分比高于吸烟者(分别为49.62%与43.82%,P = 0.000)。
我们的研究结果支持这样的假设,即吸烟等生活方式因素会对MS各组分产生不利影响。然而,我们应该认识到,这些差异可能是由于所研究的样本量较大导致的,可能没有临床意义。吸烟者中某些MS组分的患病率低于非吸烟者,可能是因为他们的人体测量指标较低。